Suchergebnisse - "Drug Repositioning"

PubPharm (97)

11

Repositioning Generic Drugs: Empirical Findings and Policy Implications

enthalten in: IIC | 2022

von Liddicoat, J. | Liddell, K. | Darrow, J. | +4

12

Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis

enthalten in: Indian journal of gastroenterology | 2022

von Thongtan, T. | Deb, A. | Vutthikraivit, W. | +4

13

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

enthalten in: Neurotherapeutics | 2022

von Palmas, M. | Ena, A. | Burgaletto, C. | +16

14

Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review

enthalten in: Medicinal chemistry research | 2021

von Oliveira, E. | Ferreira, G. | Lang, K.

15

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases

enthalten in: Digestive diseases and sciences | 2021

von van Liere, E. | Bayoumy, A. | Mulder, C. | +7

16

Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach

enthalten in: Chemické zvesti | 2021

von Yele, V. | Sanapalli, B. | Mohammed, A.

17

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

enthalten in: Molecular medicine | 2021

von Duarte, R. | Copertino, D. | Iñiguez, L. | +7

18

Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach

enthalten in: Molecular diversity | 2021

von Madugula, S. | Nagamani, S. | Jamir, E. | +2

19

Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy

enthalten in: Molecular and cellular biochemistry | 2021

von Kumar, N. | Raza, M. | Sehrawat, S.

20

Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity

enthalten in: IIC | 2021

von Liddicoat, J. | Liddell, K. | Aboy, M. | +1